The role of the autonomic nervous system in the pathophysiology of obesity

Frontiers in Physiology

Volumn 8, Issue SEP, 2017, Pages

  Guarino, Daniela ^a,b,c   Nannipieri, Monica ^a   Iervasi, Giorgio ^b   Taddei, Stefano ^a   Bruno, Rosa Maria ^a  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Adipose tissue; Autonomic nervous system; Energy expenditure; Gut hormones; Obesity; Vagal nerve blockade; Vagal nerve stimulation; Weight loss

Indexed keywords

CHOLECYSTOKININ; GHRELIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; LEPTIN; PANCREAS POLYPEPTIDE; PEPTIDE YY;

ADRENERGIC SYSTEM; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR RISK; DYSLIPIDEMIA; ENERGY EXPENDITURE; ENERGY METABOLISM; HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; KIDNEY BLOOD VESSEL; LIPOLYSIS; NEUROMODULATION; NONHUMAN; OBESITY; REVIEW; SLEEP DISORDERED BREATHING; VAGUS NERVE; WEIGHT REDUCTION;

EID: 85029677874     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2017.00665     Document Type: Review

References (240)

1. Abbott, C. R., Monteiro, M., Small, C. J., Sajedi, A., Smith, K. L., Parkinson, J. R., et al. (2005). The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 1044, 127-131. doi: 10.1016/j.brainres.2005.03.011
2. Adrian, T. E., Ferri, G. L., Bacarese-Hamilton, A. J., Fuessl, H. S., Polak, J. M., and Bloom, S. R. (1985). Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89, 1070-1077. doi: 10.1016/0016-5085(85)90211-2
3. Alvarez, G. E., Ballard, T. P., Beske, S. D., and Davy, K. P. (2004). Subcutaneous obesity is not associated with sympathetic neural activation. Am. J. Physiol. Heart Circ. Physiol. 287, H414-H418. doi: 10.1152/ajpheart.01046.2003
4. Anderson, E. A., Balon, T. W., Hoffman, R. P., Sinkey, C. A., and Mark, A. L. (1992). Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 19(6 Pt 2), 621-627. doi: 10.1161/01.HYP.19.6.621
5. Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., and Mark, A. L. (1991). Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87, 2246-2252. doi: 10.1172/JCI115260
6. Antelmi, I., de Paula, R. S., Shinzato, A. R., Peres, C. A., Mansur, A. J., and Grupi, C. J. (2004). Influence of age, gender, body mass index, and functional capacity on heart rate variability in a cohort of subjects without heart disease. Am. J. Cardiol. 93, 381-385. doi: 10.1016/j.amjcard.2003.09.065
7. Arosio, M., Ronchi, C. L., Beck-Peccoz, P., Gebbia, C., Giavoli, C., Cappiello, V., et al. (2004). Effects of modified sham feeding on ghrelin levels in healthy human subjects. J. Clin. Endocrinol. Metab. 89, 5101-5104. doi: 10.1210/jc.2003-032222
8. Asferg, C., Mogelvang, R., Flyvbjerg, A., Frystyk, J., Jensen, J. S., Marott, J. L., et al. (2010). Leptin, not adiponectin, predicts hypertension in the Copenhagen City Heart Study. Am. J. Hypertens. 23, 327-333. doi: 10.1038/ajh.2009.244
9. Asirvatham-Jeyaraj, N., Fiege, J. K., Han, R., Foss, J., Banek, C. T., Burbach, B. J., et al. (2016). Renal denervation normalizes arterial pressure with no effect on glucose metabolism or renal inflammation in obese hypertensive mice. Hypertension 68, 929-936. doi: 10.1161/HYPERTENSIONAHA.116.07993
10. Ballsmider, L. A., Vaughn, A. C., David, M., Hajnal, A., Di Lorenzo, P. M., and Czaja, K. (2015). Sleeve gastrectomy and Roux-en-Y gastric bypass alter the gut-brain communication. Neural Plast. 2015:601985. doi: 10.1155/2015/601985
11. Bartness, T. J. (2002). Dual innervation of white adipose tissue: some evidence for parasympathetic nervous system involvement. J. Clin. Invest. 110, 1235-1237. doi: 10.1172/JCI0217047
12. Baskin, D. G., Figlewicz Lattemann, D., Seeley, R. J., Woods, S. C., Porte, D. Jr., and Schwartz, M. W. (1999). Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res. 848, 114-123. doi: 10.1016/S0006-8993(99)01974-5
13. Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., et al. (2003). Inhibition of food intake in obese subjects by peptide YY3-36. N. Engl. J. Med. 349, 941-948. doi: 10.1056/NEJMoa030204
14. Berthoud, H. R. (2008a). Vagal and hormonal gut-brain communication: from satiation to satisfaction. Neurogastroenterol. Motil. 20(Suppl. 1), 64-72. doi: 10.1111/j.1365-2982.2008.01104.x
15. Berthoud, H. R. (2008b). The vagus nerve, food intake and obesity. Regul. Pept. 149, 15-25. doi: 10.1016/j.regpep.2007.08.024
16. Blessing, W. W. (1997). Inadequate frameworks for understanding bodily homeostasis. Trends Neurosci. 20, 235-239. doi: 10.1016/S0166-2236(96)01029-6
17. Bray, G. A. (1991). Obesity, a disorder of nutrient partitioning: the MONA LISA hypothesis. J. Nutr. 121, 1146-1162.
18. Brooks, D., Horner, R. L., Kozar, L. F., Render-Teixeira, C. L., and Phillipson, E. A. (1997). Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J. Clin. Invest. 99, 106-109. doi: 10.1172/JCI119120
19. Brown, L. M., Clegg, D. J., Benoit, S. C., and Woods, S. C. (2006). Intraventricular insulin and leptin reduce food intake and body weight in C57BL/6J mice. Physiol. Behav. 89, 687-691. doi: 10.1016/j.physbeh.2006.08.008
20. Bruno, R. M., Rossi, L., Fabbrini, M., Duranti, E., Di Coscio, E., Maestri, M., et al. (2013). Renal vasodilating capacity and endothelial function are impaired in patients with obstructive sleep apnea syndrome and no traditional cardiovascular risk factors. J. Hypertens 31, 1456-1464. discussion: 1464. doi: 10.1097/HJH.0b013e328360f773
21. Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., et al. (2004). Bariatric surgery: a systematic review and meta-analysis. JAMA 292, 1724-1737. doi: 10.1001/jama.292.14.1724
22. Buffa, R., Solcia, E., and Go, V. L. (1976). Immunohistochemical identification of the cholecystokinin cell in the intestinal mucosa. Gastroenterology 70, 528-532.
23. Bugajski, A. J., Gil, K., Ziomber, A., Zurowski, D., Zaraska, W., and Thor, P. J. (2007). Effect of long-term vagal stimulation on food intake and body weight during diet induced obesity in rats. J. Physiol. Pharmacol. 58(Suppl.1), 5-12.
24. Bullock, B. P., Heller, R. S., and Habener, J. F. (1996). Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137, 2968-2978. doi: 10.1210/endo.137.7.8770921
25. Burdyga, G., Lal, S., Spiller, D., Jiang, W., Thompson, D., Attwood, S., et al. (2003). Localization of orexin-1 receptors to vagal afferent neurons in the rat and humans. Gastroenterology 124, 129-139. doi: 10.1053/gast.2003.50020
26. Burton-Freeman, B., Davis, P. A., and Schneeman, B. O. (2002). Plasma cholecystokinin is associated with subjective measures of satiety in women. Am. J. Clin. Nutr. 76, 659-667.
27. Camilleri, M., Toouli, J., Herrera, M. F., Kulseng, B., Kow, L., Pantoja, J. P., et al. (2008). Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. Surgery 143, 723-731. doi: 10.1016/j.surg.2008.03.015
28. Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., and Burn, P. (1995). Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546-549. doi: 10.1126/science.7624778
29. Cannon, B., and Nedergaard, J. (2004). Brown adipose tissue: function and physiological significance. Physiol. Rev. 84, 277-359. doi: 10.1152/physrev.00015.2003
30. Capasso, R., and Izzo, A. A. (2008). Gastrointestinal regulation of food intake: general aspects and focus on anandamide and oleoylethanolamide. J. Neuroendocrinol. 20(Suppl. 1), 39-46. doi: 10.1111/j.1365-2826.2008.01686.x
31. Carey, A. L., Formosa, M. F., Van Every, B., Bertovic, D., Eikelis, N., Lambert, G. W., et al. (2013). Ephedrine activates brown adipose tissue in lean but not obese humans. Diabetologia 56, 147-155. doi: 10.1007/s00125-012-2748-1
32. Chazova, I., and Schlaich, M. P. (2013). Improved hypertension control with the imidazoline agonist moxonidine in a multinational metabolic syndrome population: principal results of the MERSY study. Int. J. Hypertens. 2013:541689. doi: 10.1155/2013/541689
33. Cheng, W., Zhu, Z., Jin, X., Chen, L., Zhuang, H., and Li, F. (2012). Intense FDG activity in the brown adipose tissue in omental and mesenteric regions in a patient with malignant pheochromocytoma. Clin. Nucl. Med. 37, 514-515. doi: 10.1097/RLU.0b013e31824d2121
34. Clancy, J. A., Mary, D. A., Witte, K. K., Greenwood, J. P., Deuchars, S. A., and Deuchars, J. (2014). Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity. Brain Stimul. 7, 871-877. doi: 10.1016/j.brs.2014.07.031
35. Considine, R. V., Considine, E. L., Williams, C. J., Hyde, T. M., and Caro, J. F. (1996). The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes 45, 992-994. doi: 10.2337/diab.45.7.992
36. Corp, E. S., McQuade, J., Moran, T. H., and Smith, G. P. (1993). Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Brain Res. 623, 161-166. doi: 10.1016/0006-8993(93)90024-H
37. Correia, M. L., Haynes, W. G., Rahmouni, K., Morgan, D. A., Sivitz, W. I., and Mark, A. L. (2002). The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 51, 439-442. doi: 10.2337/diabetes.51.2.439
38. Cousin, B., Cinti, S., Morroni, M., Raimbault, S., Ricquier, D., Penicaud, L., et al. (1992). Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J. Cell Sci. 103(Pt 4), 931-942.
39. Cox, H. M. (2007a). Neuropeptide Y receptors; antisecretory control of intestinal epithelial function. Auton. Neurosci. 133, 76-85. doi: 10.1016/j.autneu.2006.10.005
40. Cox, H. M. (2007b). Peptide YY: a neuroendocrine neighbor of note. Peptides 28, 345-351. doi: 10.1016/j.peptides.2006.07.023
41. Cruickshank, J. M. (2017). The role of beta-blockers in the treatment of hypertension. Adv. Exp. Med. Biol. 956, 149-166. doi: 10.1007/5584_2016_36
42. Cummings, D. E. (2006). Ghrelin and the short-and long-term regulation of appetite and body weight. Physiol. Behav. 89, 71-84. doi: 10.1016/j.physbeh.2006.05.022
43. Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., and Weigle, D. S. (2001). A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714-1719. doi: 10.2337/diabetes.50.8.1714
44. Cummings, D. E., and Schwartz, M. W. (2003). Genetics and pathophysiology of human obesity. Annu. Rev. Med. 54, 453-471. doi: 10.1146/annurev.med.54.101601.152403
45. Cummings, D. E., Weigle, D. S., Frayo, R. S., Breen, P. A., Ma, M. K., Dellinger, E. P., et al. (2002). Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 346, 1623-1630. doi: 10.1056/NEJMoa012908
46. Curry, T. B., Somaraju, M., Hines, C. N., Groenewald, C. B., Miles, J. M., Joyner, M. J., et al. (2013). Sympathetic support of energy expenditure and sympathetic nervous system activity after gastric bypass surgery. Obesity 21, 480-485. doi: 10.1002/oby.20106
47. Date, Y., Murakami, N., Toshinai, K., Matsukura, S., Niijima, A., Matsuo, H., et al. (2002). The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123, 1120-1128. doi: 10.1053/gast.2002.35954
48. Dempsey, J. A., Veasey, S. C., Morgan, B. J., and O'Donnell, C. P. (2010). Pathophysiology of sleep apnea. Physiol. Rev. 90, 47-112. doi: 10.1152/physrev.00043.2008
49. DiBona, G. F. (1992). Sympathetic neural control of the kidney in hypertension. Hypertension 19, I28-I35. doi: 10.1161/01.HYP.19.1_Suppl.I28
50. Dockray, G. J. (2014). Gastrointestinal hormones and the dialogue between gut and brain. J. Physiol. 592, 2927-2941. doi: 10.1113/jphysiol.2014.270850
51. Dumont, Y., Fournier, A., St-Pierre, S., and Quirion, R. (1995). Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31, Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands. J. Pharmacol. Exp. Ther. 272, 673-680.
52. Dumoulin, V., Dakka, T., Plaisancie, P., Chayvialle, J. A., and Cuber, J. C. (1995). Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum. Endocrinology 136, 5182-5188. doi: 10.1210/endo.136.11.7588257
53. Dunbar, J. C., Hu, Y., and Lu, H. (1997). Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 46, 2040-2043. doi: 10.2337/diab.46.12.2040
54. Edvell, A., and Lindstrom, P. (1999). Initiation of increased pancreatic islet growth in young normoglycemic mice (Umea +/?). Endocrinology 140, 778-783. doi: 10.1210/endo.140.2.6514
55. Ekblad, E., and Sundler, F. (2002). Distribution of pancreatic polypeptide and peptide YY. Peptides 23, 251-261. doi: 10.1016/S0196-9781(01)00601-5
56. Elias, C. F., Kelly, J. F., Lee, C. E., Ahima, R. S., Drucker, D. J., Saper, C. B., et al. (2000). Chemical characterization of leptin-activated neurons in the rat brain. J. Comp. Neurol. 423, 261-281. doi: 10.1002/1096-9861(20000724)423:2<261::AID-CNE6>3.0.CO;2-6
57. Elmquist, J. K., Ahima, R. S., Maratos-Flier, E., Flier, J. S., and Saper, C. B. (1997). Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology 138, 839-842. doi: 10.1210/endo.138.2.5033
58. Elmquist, J. K., Maratos-Flier, E., Saper, C. B., and Flier, J. S. (1998). Unraveling the central nervous system pathways underlying responses to leptin. Nat. Neurosci. 1, 445-450. doi: 10.1038/2164
59. Emdin, M., Gastaldelli, A., Muscelli, E., Macerata, A., Natali, A., Camastra, S., et al. (2001). Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss. Circulation 103, 513-519. doi: 10.1161/01.CIR.103.4.513
60. English, P. J., Ghatei, M. A., Malik, I. A., Bloom, S. R., and Wilding, J. P. (2002). Food fails to suppress ghrelin levels in obese humans. J. Clin. Endocrinol. Metab. 87:2984. doi: 10.1210/jcem.87.6.8738
61. Esler, M., Straznicky, N., Eikelis, N., Masuo, K., Lambert, G., and Lambert, E. (2006). Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 48, 787-796. doi: 10.1161/01.HYP.0000242642.42177.49
62. Feldstein, C., and Julius, S. (2009). The complex interaction between overweight, hypertension, and sympathetic overactivity. J. Am. Soc. Hypertens. 3, 353-365. doi: 10.1016/j.jash.2009.10.001
63. Ferrannini, E. (1998). Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr. Rev. 19, 477-490. doi: 10.1210/edrv.19.4.0336
64. Fetissov, S. O., Kopp, J., and Hokfelt, T. (2004). Distribution of NPY receptors in the hypothalamus. Neuropeptides 38, 175-188. doi: 10.1016/j.npep.2004.05.009
65. Fink, H., Rex, A., Voits, M., and Voigt, J. P. (1998). Major biological actions of CCK-a critical evaluation of research findings. Exp. Brain Res. 123, 77-83. doi: 10.1007/s002210050546
66. Fischer, A. W., Hoefig, C. S., Abreu-Vieira, G., de Jong, J. M., Petrovic, N., Mittag, J., et al. (2016). Leptin raises defended body temperature without activating thermogenesis. Cell Rep. 14, 1621-1631. doi: 10.1016/j.celrep.2016.01.041
67. Flier, J. S. (2001). Diabetes. The missing link with obesity? Nature 409, 292-293. doi: 10.1038/35053251
68. Forster, E. R., Green, T., Elliot, M., Bremner, A., and Dockray, G. J. (1990). Gastric emptying in rats: role of afferent neurons and cholecystokinin. Am. J. Physiol. 258(4 Pt 1), G552-G556.
69. Frangos, E., Ellrich, J., and Komisaruk, B. R. (2015). Non-invasive access to the vagus nerve central projections via electrical stimulation of the external ear: fMRI evidence in humans. Brain Stimul. 8, 624-636. doi: 10.1016/j.brs.2014.11.018
70. Frost, G. S., Brynes, A. E., Dhillo, W. S., Bloom, S. R., and McBurney, M. I. (2003). The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal. Eur. J. Clin. Nutr. 57, 293-298. doi: 10.1038/sj.ejcn.1601520
71. Fu-Cheng, X., Anini, Y., Chariot, J., Castex, N., Galmiche, J. P., and Roze, C. (1997). Mechanisms of peptide YY release induced by an intraduodenal meal in rats: neural regulation by proximal gut. Pflugers Arch. 433, 571-579. doi: 10.1007/s004240050316
72. Gamboa, A., Figueroa, R., Paranjape, S. Y., Farley, G., Diedrich, A., and Biaggioni, I. (2016). Autonomic blockade reverses endothelial dysfunction in obesity-associated hypertension. Hypertension 68, 1004-1010. doi: 10.1161/HYPERTENSIONAHA.116.07681
73. Gamboa, A., Okamoto, L. E., Arnold, A. C., Figueroa, R. A., Diedrich, A., Raj, S. R., et al. (2014). Autonomic blockade improves insulin sensitivity in obese subjects. Hypertension 64, 867-874. doi: 10.1161/HYPERTENSIONAHA.114.03738
74. Gilgen, A., Maickel, R. P., Nikodijevic, O., and Brodie, B. B. (1962). Essential role of catecholamines in the mobilization of free fatty acids and glucose after exposure to cold. Life Sci. 1, 709-715. doi: 10.1016/0024-3205(62)90138-8
75. Giordano, A., Song, C. K., Bowers, R. R., Ehlen, J. C., Frontini, A., Cinti, S., et al. (2006). White adipose tissue lacks significant vagal innervation and immunohistochemical evidence of parasympathetic innervation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, R1243-R1255. doi: 10.1152/ajpregu.00679.2005
76. Glaser, B., Zoghlin, G., Pienta, K., and Vinik, A. I. (1988). Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance. Horm. Metab. Res. 20, 288-292. doi: 10.1055/s-2007-1010817
77. Golan, E., Tal, B., Dror, Y., Korzets, Z., Vered, Y., Weiss, E., et al. (2002). Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension. Isr. Med. Assoc. J. 4, 426-430.
78. Goodridge, A. G., and Ball, E. G. (1965). Studies on the metabolism of adipose tissue. 18. In vitro effects of insulin, epinephrine and glucagon on lipolysis and glycolysis in pigeon adipose tissue. Comp. Biochem. Physiol. 16, 367-381. doi: 10.1016/0010-406X(65)90303-8
79. Goran, M. I. (2000). Energy metabolism and obesity. Med. Clin. North Am. 84, 347-362. doi: 10.1016/S0025-7125(05)70225-X
80. Granger, D. N., Richardson, P. D., Kvietys, P. R., and Mortillaro, N. A. (1980). Intestinal blood flow. Gastroenterology 78, 837-863.
81. Grassi, G., Dell'Oro, R., Facchini, A., Quarti Trevano, F., Bolla, G. B., and Mancia, G. (2004). Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J. Hypertens. 22, 2363-2369. doi: 10.1097/00004872-200412000-00019
82. Grassi, G., Facchini, A., Trevano, F. Q., Dell'Oro, R., Arenare, F., Tana, F., et al. (2005). Obstructive sleep apnea-dependent and-independent adrenergic activation in obesity. Hypertension 46, 321-325. doi: 10.1161/01.HYP.0000174243.39897.6c
83. Grassi, G., Mark, A., and Esler, M. (2015). The sympathetic nervous system alterations in human hypertension. Circ. Res. 116, 976-990. doi: 10.1161/CIRCRESAHA.116.303604
84. Grassi, G., Seravalle, G., Cattaneo, B. M., Bolla, G. B., Lanfranchi, A., Colombo, M., et al. (1995). Sympathetic activation in obese normotensive subjects. Hypertension 25(4 Pt 1), 560-563. doi: 10.1161/01.HYP.25.4.560
85. Greenfield, J. R., Miller, J. W., Keogh, J. M., Henning, E., Satterwhite, J. H., Cameron, G. S., et al. (2009). Modulation of blood pressure by central melanocortinergic pathways. N. Engl. J. Med. 360, 44-52. doi: 10.1056/NEJMoa0803085
86. Hall, J. E., Granger, J. P., do Carmo, J. M., da Silva, A. A., Dubinion, J., George, E., et al. (2012). Hypertension: physiology and pathophysiology. Compr. Physiol. 2, 2393-2442. doi: 10.1002/cphy.c110058
87. Hall, J. E., Hildebrandt, D. A., and Kuo, J. (2001). Obesity hypertension: role of leptin and sympathetic nervous system. Am. J. Hypertens. 14(6 Pt 2), 103S-115S. doi: 10.1016/S0895-7061(01)02077-5
88. Hausberg, M., Hoffman, R. P., Somers, V. K., Sinkey, C. A., Mark, A. L., and Anderson, E. A. (1997). Contrasting autonomic and hemodynamic effects of insulin in healthy elderly versus young subjects. Hypertension 29, 700-705. doi: 10.1161/01.HYP.29.3.700
89. Haynes, W. G. (2000). Interaction between leptin and sympathetic nervous system in hypertension. Curr. Hypertens. Rep. 2, 311-318. doi: 10.1007/s11906-000-0015-1
90. Haynes, W. G., Morgan, D. A., Djalali, A., Sivitz, W. I., and Mark, A. L. (1999). Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 33(1 Pt 2), 542-547. doi: 10.1161/01.HYP.33.1.542
91. Haynes, W. G., Sivitz, W. I., Morgan, D. A., Walsh, S. A., and Mark, A. L. (1997). Sympathetic and cardiorenal actions of leptin. Hypertension 30(3 Pt 2), 619-623. doi: 10.1161/01.HYP.30.3.619
92. Heath, R. B., Jones, R., Frayn, K. N., and Robertson, M. D. (2004). Vagal stimulation exaggerates the inhibitory ghrelin response to oral fat in humans. J. Endocrinol. 180, 273-281. doi: 10.1677/joe.0.1800273
93. Henry, T. R. (2002). Therapeutic mechanisms of vagus nerve stimulation. Neurology 59(6 Suppl. 4), S3-S14. doi: 10.1212/WNL.59.6_suppl_4.S3
94. Heymsfield, S. B., Greenberg, A. S., Fujioka, K., Dixon, R. M., Kushner, R., Hunt, T., et al. (1999). Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 282, 1568-1575. doi: 10.1001/jama.282.16.1568
95. Hirsch, J., Leibel, R. L., Mackintosh, R., and Aguirre, A. (1991). Heart rate variability as a measure of autonomic function during weight change in humans. Am. J. Physiol. 261(6 Pt 2), R1418-R1423.
96. Holst, J. J., Orskov, C., Nielsen, O. V., and Schwartz, T. W. (1987). Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett. 211, 169-174. doi: 10.1016/0014-5793(87)81430-8
97. Huang, F., Dong, J., Kong, J., Wang, H., Meng, H., Spaeth, R. B., et al. (2014). Effect of transcutaneous auricular vagus nerve stimulation on impaired glucose tolerance: a pilot randomized study. BMC Complement. Altern. Med. 14:203. doi: 10.1186/1472-6882-14-203
98. Id, D., Bertog, S. C., Ziegler, A. K., Hornung, M., Hofmann, I., Vaskelyte, L., et al. (2016). Predictors of blood pressure response: obesity is associated with a less pronounced treatment response after renal denervation. Catheter. Cardiovasc. Interv. 87, E30-E38. doi: 10.1002/ccd.26068
99. Ikramuddin, S., Blackstone, R. P., Brancatisano, A., Toouli, J., Shah, S. N., Wolfe, B. M., et al. (2014). Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. JAMA 312, 915-922. doi: 10.1001/jama.2014.10540
100. Imeryuz, N., Yegen, B. C., Bozkurt, A., Coskun, T., Villanueva-Penacarrillo, M. L., and Ulusoy, N. B. (1997). Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am. J. Physiol. 273(4 Pt 1), G920-G927.
101. Inokuma, K., Okamatsu-Ogura, Y., Omachi, A., Matsushita, Y., Kimura, K., Yamashita, H., et al. (2006). Indispensable role of mitochondrial UCP1 for antiobesity effect of beta3-adrenergic stimulation. Am. J. Physiol. Endocrinol. Metab. 290, E1014-E1021. doi: 10.1152/ajpendo.00105.2005
102. Iwasaki, Y., Shimomura, K., Kohno, D., Dezaki, K., Ayush, E. A., Nakabayashi, H., et al. (2013). Insulin activates vagal afferent neurons including those innervating pancreas via insulin cascade and Ca(2+)influx: its dysfunction in IRS2-KO mice with hyperphagic obesity. PLoS ONE 8:e67198. doi: 10.1371/journal.pone.0067198
103. Iyer, M. S., Bergman, R. N., Korman, J. E., Woolcott, O. O., Kabir, M., Victor, R. G., et al. (2016). Renal denervation reverses hepatic insulin resistance induced by high-fat diet. Diabetes 65, 3453-3463. doi: 10.2337/db16-0698
104. Jorde, R., and Burhol, P. G. (1984). Fasting and postprandial plasma pancreatic polypeptide (PP) levels in obesity. Int. J. Obes. 8, 393-397.
105. Julius, S., Valentini, M., and Palatini, P. (2000). Overweight and hypertension: a 2-way street? Hypertension 35, 807-813. doi: 10.1161/01.HYP.35.3.807
106. Kassab, S., Kato, T., Wilkins, F. C., Chen, R., Hall, J. E., and Granger, J. P. (1995). Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 25(4 Pt 2), 893-897. doi: 10.1161/01.HYP.25.4.893
107. Kastin, A. J., Akerstrom, V., and Pan, W. (2002). Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J. Mol. Neurosci. 18, 7-14. doi: 10.1385/JMN:18:1-2:07
108. Kissileff, H. R., Carretta, J. C., Geliebter, A., and Pi-Sunyer, F. X. (2003). Cholecystokinin and stomach distension combine to reduce food intake in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R992-R998. doi: 10.1152/ajpregu.00272.2003
109. Koda, S., Date, Y., Murakami, N., Shimbara, T., Hanada, T., Toshinai, K., et al. (2005). The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 146, 2369-2375. doi: 10.1210/en.2004-1266
110. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., and Kangawa, K. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660. doi: 10.1038/45230
111. Kral, J. G. (1978). Vagotomy for treatment of severe obesity. Lancet 1, 307-308. doi: 10.1016/S0140-6736(78)90074-0
112. Kreier, F., Fliers, E., Voshol, P. J., Van Eden, C. G., Havekes, L. M., Kalsbeek, A., et al. (2002). Selective parasympathetic innervation of subcutaneous and intra-abdominal fat-functional implications. J. Clin. Invest. 110, 1243-1250. doi: 10.1172/JCI0215736
113. Kreymann, B., Williams, G., Ghatei, M. A., and Bloom, S. R. (1987). Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2, 1300-1304. doi: 10.1016/S0140-6736(87)91194-9
114. Kuniyoshi, F. H., Trombetta, I. C., Batalha, L. T., Rondon, M. U., Laterza, M. C., Gowdak, M. M., et al. (2003). Abnormal neurovascular control during sympathoexcitation in obesity. Obes. Res. 11, 1411-1419. doi: 10.1038/oby.2003.190
115. Kunz, I., Schorr, U., Klaus, S., and Sharma, A. M. (2000). Resting metabolic rate and substrate use in obesity hypertension. Hypertension 36, 26-32. doi: 10.1161/01.HYP.36.1.26
116. Lambert, E. A., Rice, T., Eikelis, N., Straznicky, N. E., Lambert, G. W., Head, G. A., et al. (2014). Sympathetic activity and markers of cardiovascular risk in nondiabetic severely obese patients: the effect of the initial 10% weight loss. Am. J. Hypertens. 27, 1308-1315. doi: 10.1093/ajh/hpu050
117. Lambert, E. A., Straznicky, N. E., Dixon, J. B., and Lambert, G. W. (2015). Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity? Am. J. Physiol. Heart Circ. Physiol. 309, H244-H258. doi: 10.1152/ajpheart.00096.2015
118. Lambert, E., Lambert, G., Ika-Sari, C., Dawood, T., Lee, K., Chopra, R., et al. (2011). Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men. Hypertension 58, 43-50. doi: 10.1161/HYPERTENSIONAHA.111.171025
119. Lambert, E., Sari, C. I., Dawood, T., Nguyen, J., McGrane, M., Eikelis, N., et al. (2010). Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 56, 351-358. doi: 10.1161/HYPERTENSIONAHA.110.155663
120. Lambert, E., Straznicky, N., Schlaich, M., Esler, M., Dawood, T., Hotchkin, E., et al. (2007). Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension 50, 862-868. doi: 10.1161/HYPERTENSIONAHA.107.094649
121. Landsberg, L. (1986). Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q. J. Med. 61, 1081-1090.
122. Landsberg, L. (2001). Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J. Hypertens 19(3 Pt 2), 523-528. doi: 10.1097/00004872-200103001-00001
123. Lassmann, V., Vague, P., Vialettes, B., and Simon, M. C. (1980). Low plasma levels of pancreatic polypeptide in obesity. Diabetes 29, 428-430. doi: 10.2337/diab.29.6.428
124. Lavin, J. H., Wittert, G. A., Andrews, J., Yeap, B., Wishart, J. M., Morris, H. A., et al. (1998). Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate. Am. J. Clin. Nutr. 68, 591-598.
125. Lebron, L., Chou, A. J., and Carrasquillo, J. A. (2010). Interesting image. Unilateral F-18 FDG uptake in the neck, in patients with sympathetic denervation. Clin. Nucl. Med. 35, 899-901. doi: 10.1097/RLU.0b013e3181f49ff8
126. Lee, H. M., Wang, G., Englander, E. W., Kojima, M., and Greeley, G. H. Jr. (2002). Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 143, 185-190. doi: 10.1210/endo.143.1.8602
127. Le Roux, C. W., Batterham, R. L., Aylwin, S. J., Patterson, M., Borg, C. M., Wynne, K. J., et al. (2006). Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147, 3-8. doi: 10.1210/en.2005-0972
128. Li, Y., and Owyang, C. (1994). Endogenous cholecystokinin stimulates pancreatic enzyme secretion via vagal afferent pathway in rats. Gastroenterology 107, 525-531. doi: 10.1016/0016-5085(94)90180-5
129. Lim, K., Burke, S. L., and Head, G. A. (2013). Obesity-related hypertension and the role of insulin and leptin in high-fat-fed rabbits. Hypertension 61, 628-634. doi: 10.1161/HYPERTENSIONAHA.111.00705
130. Lin, H. C., and Taylor, I. L. (2004). Release of peptide YY by fat in the proximal but not distal gut depends on an atropine-sensitive cholinergic pathway. Regul. Pept. 117, 73-76. doi: 10.1016/j.regpep.2003.10.008
131. Lips, M. A., de Groot, G. H., De Kam, M., Berends, F. J., Wiezer, R., Van Wagensveld, B. A., et al. (2013). Autonomic nervous system activity in diabetic and healthy obese female subjects and the effect of distinct weight loss strategies. Eur. J. Endocrinol. 169, 383-390. doi: 10.1530/EJE-13-0506
132. Little, T. J., Horowitz, M., and Feinle-Bisset, C. (2005). Role of cholecystokinin in appetite control and body weight regulation. Obes. Rev. 6, 297-306. doi: 10.1111/j.1467-789X.2005.00212.x
133. Mahfoud, F., Schlaich, M., Kindermann, I., Ukena, C., Cremers, B., Brandt, M. C., et al. (2011). Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 123, 1940-1946. doi: 10.1161/CIRCULATIONAHA.110.991869
134. Mano-Otagiri, A., Ohata, H., Iwasaki-Sekino, A., Nemoto, T., and Shibasaki, T. (2009). Ghrelin suppresses noradrenaline release in the brown adipose tissue of rats. J. Endocrinol. 201, 341-349. doi: 10.1677/JOE-08-0374
135. Mark, A. L. (2013). Selective leptin resistance revisited. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305, R566-R581. doi: 10.1152/ajpregu.00180.2013
136. Mark, A. L., Correia, M. L., Rahmouni, K., and Haynes, W. G. (2002). Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J. Hypertens. 20, 1245-1250. doi: 10.1097/00004872-200207000-00001
137. Mark, A. L., Shaffer, R. A., Correia, M. L., Morgan, D. A., Sigmund, C. D., and Haynes, W. G. (1999). Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J. Hypertens 17(12 Pt 2), 1949-1953. doi: 10.1097/00004872-199917121-00026
138. Marsh, A. J., Fontes, M. A., Killinger, S., Pawlak, D. B., Polson, J. W., and Dampney, R. A. (2003). Cardiovascular responses evoked by leptin acting on neurons in the ventromedial and dorsomedial hypothalamus. Hypertension 42, 488-493. doi: 10.1161/01.HYP.0000090097.22678.0A
139. Martin-Rodriguez, E., Guillen-Grima, F., Marti, A., and Brugos-Larumbe, A. (2015). Comorbidity associated with obesity in a large population: the APNA study. Obes. Res. Clin. Pract. 9, 435-447. doi: 10.1016/j.orcp.2015.04.003
140. Masajtis-Zagajewska, A., Majer, J., and Nowicki, M. (2010). Effect of moxonidine and amlodipine on serum YKL-40, plasma lipids and insulin sensitivity in insulin-resistant hypertensive patients-a randomized, crossover trial. Hypertens. Res. 33, 348-353. doi: 10.1038/hr.2010.6
141. Matsumoto, T., Miyawaki, T., Ue, H., Kanda, T., Zenji, C., and Moritani, T. (1999). Autonomic responsiveness to acute cold exposure in obese and non-obese young women. Int. J. Obes. Relat. Metab. Disord. 23, 793-800. doi: 10.1038/sj.ijo.0800928
142. Matsumura, K., Tsuchihashi, T., Fujii, K., Abe, I., and Iida, M. (2002). Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension 40, 694-699. doi: 10.1161/01.HYP.0000035395.51441.10
143. Meguro, T., Shimosegawa, T., Kikuchi, Y., Koizumi, M., and Toyota, T. (1995). Effects of cisapride on gallbladder emptying and pancreatic polypeptide and cholecystokinin release in humans. J. Gastroenterol. 30, 237-243. doi: 10.1007/BF02348671
144. Messerli, F. H., Sundgaard-Riise, K., Reisin, E., Dreslinski, G., Dunn, F. G., and Frohlich, E. (1983). Disparate cardiovascular effects of obesity and arterial hypertension. Am. J. Med. 74, 808-812. doi: 10.1016/0002-9343(83)91071-9
145. Miro, J., Jaraba, S., Mora, J., Puig, O., Castaner, S., Rodriguez-Bel, L., et al. (2015). Vagus nerve stimulation therapy is effective and safe for startle-induced seizures. J. Neurol. Sci. 354, 124-126. doi: 10.1016/j.jns.2015.04.048
146. Mojsov, S., Weir, G. C., and Habener, J. F. (1987). Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J. Clin. Invest. 79, 616-619. doi: 10.1172/JCI112855
147. Monroe, M. B., Seals, D. R., Shapiro, L. F., Bell, C., Johnson, D., and Parker Jones, P. (2001). Direct evidence for tonic sympathetic support of resting metabolic rate in healthy adult humans. Am. J. Physiol. Endocrinol. Metab. 280, E740-E744.
148. Moran, T. H., and Kinzig, K. P. (2004). Gastrointestinal satiety signals II. Cholecystokinin. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G183-G188. doi: 10.1152/ajpgi.00434.2003
149. Muscelli, E., Emdin, M., Natali, A., Pratali, L., Camastra, S., Gastaldelli, A., et al. (1998). Autonomic and hemodynamic responses to insulin in lean and obese humans. J. Clin. Endocrinol. Metab. 83, 2084-2090. doi: 10.1210/jc.83.6.2084
150. Nakabayashi, H., Nishizawa, M., Nakagawa, A., Takeda, R., and Niijima, A. (1996). Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am. J. Physiol. 271(5 Pt 1), E808-E813.
151. Nannipieri, M., Mari, A., Anselmino, M., Baldi, S., Barsotti, E., Guarino, D., et al. (2011). The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J. Clin. Endocrinol. Metab. 96, E1372-E1379. doi: 10.1210/jc.2011-0446
152. Narkiewicz, K., Kato, M., Pesek, C. A., and Somers, V. K. (1999a). Human obesity is characterized by a selective potentiation of central chemoreflex sensitivity. Hypertension 33, 1153-1158. doi: 10.1161/01.HYP.33.5.1153
153. Narkiewicz, K., Kato, M., Phillips, B. G., Pesek, C. A., Davison, D. E., and Somers, V. K. (1999b). Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100, 2332-2335. doi: 10.1161/01.CIR.100.23.2332
154. Narkiewicz, K., van de Borne, P. J., Cooley, R. L., Dyken, M. E., and Somers, V. K. (1998). Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98, 772-776. doi: 10.1161/01.CIR.98.8.772
155. Nault, I., Nadreau, E., Paquet, C., Brassard, P., Marceau, P., Marceau, S., et al. (2007). Impact of bariatric surgery-induced weight loss on heart rate variability. Metab. Clin. Exp. 56, 1425-1430. doi: 10.1016/j.metabol.2007.06.006
156. Neary, N. M., Small, C. J., and Bloom, S. R. (2003). Gut and mind. Gut 52, 918-921. doi: 10.1136/gut.52.7.918
157. Negrao, C. E., Trombetta, I. C., Batalha, L. T., Ribeiro, M. M., Rondon, M. U., Tinucci, T., et al. (2001). Muscle metaboreflex control is diminished in normotensive obese women. Am. J. Physiol. Heart Circ. Physiol. 281, H469-H475.
158. Niebel, W., Eysselein, V. E., and Singer, M. V. (1987). Pancreatic polypeptide response to a meal before and after cutting the extrinsic nerves of the upper gastrointestinal tract and the pancreas in the dog. Dig. Dis. Sci. 32, 1004-1009. doi: 10.1007/BF01297191
159. Obici, S., and Rossetti, L. (2003). Minireview: nutrient sensing and the regulation of insulin action and energy balance. Endocrinology 144, 5172-5178. doi: 10.1210/en.2003-0999
160. Obici, S., Zhang, B. B., Karkanias, G., and Rossetti, L. (2002). Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 8, 1376-1382. doi: 10.1038/nm1202-798
161. Onaga, T., Zabielski, R., and Kato, S. (2002). Multiple regulation of peptide YY secretion in the digestive tract. Peptides 23, 279-290. doi: 10.1016/S0196-9781(01)00609-X
162. Orskov, C., Rabenhoj, L., Wettergren, A., Kofod, H., and Holst, J. J. (1994). Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43, 535-539. doi: 10.2337/diab.43.4.535
163. Ozata, M., Ozdemir, I. C., and Licinio, J. (1999). Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J. Clin. Endocrinol. Metab. 84, 3686-3695. doi: 10.1210/jcem.84.10.5999
164. Pandit, R., Beerens, S., and Adan, R. A. H. (2017). Role of leptin in energy expenditure: the hypothalamic perspective. Am. J. Physiol. Regul. Integr. Comp. Physiol. 312, R938-R947. doi: 10.1152/ajpregu.00045.2016
165. Pardo, J. V., Sheikh, S. A., Kuskowski, M. A., Surerus-Johnson, C., Hagen, M. C., Lee, J. T., et al. (2007). Weight loss during chronic, cervical vagus nerve stimulation in depressed patients with obesity: an observation. Int. J. Obes. 31, 1756-1759. doi: 10.1038/sj.ijo.0803666
166. Parker, R. M., and Herzog, H. (1999). Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 11, 1431-1448. doi: 10.1046/j.1460-9568.1999.00553.x
167. Perugini, R. A., Li, Y., Rosenthal, L., Gallagher-Dorval, K., Kelly, J. J., and Czerniach, D. R. (2010). Reduced heart rate variability correlates with insulin resistance but not with measures of obesity in population undergoing laparoscopic Roux-en-Y gastric bypass. Surg. Obes. Relat. Dis. 6, 237-241. doi: 10.1016/j.soard.2009.09.012
168. Peuker, E. T., and Filler, T. J. (2002). The nerve supply of the human auricle. Clin. Anat. 15, 35-37. doi: 10.1002/ca.1089
169. Plamboeck, A., Veedfald, S., Deacon, C. F., Hartmann, B., Wettergren, A., Svendsen, L. B., et al. (2013). The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G1117-G1127. doi: 10.1152/ajpgi.00035.2013
170. Plum, L., Schubert, M., and Bruning, J. C. (2005). The role of insulin receptor signaling in the brain. Trends Endocrinol. Metab. 16, 59-65. doi: 10.1016/j.tem.2005.01.008
171. Pontiroli, A. E., Merlotti, C., Veronelli, A., and Lombardi, F. (2013). Effect of weight loss on sympatho-vagal balance in subjects with grade-3 obesity: restrictive surgery versus hypocaloric diet. Acta Diabetol. 50, 843-850. doi: 10.1007/s00592-013-0454-1
172. Prigge, W. F., and Grande, F. (1971). Effects of glucagon, epinephrine and insulin on in vitro lipolysis of adipose tissue from mammals and birds. Comp. Biochem. Physiol. B 39, 69-82. doi: 10.1016/0305-0491(71)90254-9
173. Prior, L. J., Davern, P. J., Burke, S. L., Lim, K., Armitage, J. A., and Head, G. A. (2014). Exposure to a high-fat diet during development alters leptin and ghrelin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 63, 338-345. doi: 10.1161/HYPERTENSIONAHA.113.02498
174. Rahmouni, K., Morgan, D. A., Morgan, G. M., Mark, A. L., and Haynes, W. G. (2005). Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 54, 2012-2018. doi: 10.2337/diabetes.54.7.2012
175. Rebuffe-Scrive, M. (1991). Neuroregulation of adipose tissue: molecular and hormonal mechanisms. Int. J. Obes. 15(Suppl. 2), 83-86.
176. Rong, P., Liu, J., Wang, L., Liu, R., Fang, J., Zhao, J., et al. (2016). Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder: a nonrandomized controlled pilot study. J. Affect. Disord. 195, 172-179. doi: 10.1016/j.jad.2016.02.031
177. Ronveaux, C. C., Tome, D., and Raybould, H. E. (2015). Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling. J. Nutr. 145, 672-680. doi: 10.3945/jn.114.206029
178. Rosell, S. (1966). Release of free fatty acids from subcutaneous adipose tissue in dogs following sympathetic nerve stimulation. Acta Physiol. Scand. 67, 343-351. doi: 10.1111/j.1748-1716.1966.tb03320.x
179. Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., and Landsberg, L. (1981). Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30, 219-225. doi: 10.2337/diab.30.3.219
180. Saito, M. (2013). Brown adipose tissue as a regulator of energy expenditure and body fat in humans. Diabetes Metab. J. 37, 22-29. doi: 10.4093/dmj.2013.37.1.22
181. Saito, M., Okamatsu-Ogura, Y., Matsushita, M., Watanabe, K., Yoneshiro, T., Nio-Kobayashi, J., et al. (2009). High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 58, 1526-1531. doi: 10.2337/db09-0530
182. Sarr, M. G., Billington, C. J., Brancatisano, R., Brancatisano, A., Toouli, J., Kow, L., et al. (2012). The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity. Obes. Surg. 22, 1771-1782. doi: 10.1007/s11695-012-0751-8
183. Sartor, D. M., and Verberne, A. J. (2002). Cholecystokinin selectively affects presympathetic vasomotor neurons and sympathetic vasomotor outflow. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R1174-R1184. doi: 10.1152/ajpregu.00500.2001
184. Sartor, D. M., and Verberne, A. J. (2006). The sympathoinhibitory effects of systemic cholecystokinin are dependent on neurons in the caudal ventrolateral medulla in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, R1390-R1398. doi: 10.1152/ajpregu.00314.2006
185. Sartor, D. M., and Verberne, A. J. (2008). Abdominal vagal signalling: a novel role for cholecystokinin in circulatory control? Brain Res. Rev. 59, 140-154. doi: 10.1016/j.brainresrev.2008.07.002
186. Satoh, N., Ogawa, Y., Katsuura, G., Hayase, M., Tsuji, T., Imagawa, K., et al. (1997). The arcuate nucleus as a primary site of satiety effect of leptin in rats. Neurosci. Lett. 224, 149-152. doi: 10.1016/S0304-3940(97)00163-8
187. Scherer, T., O'Hare, J., Diggs-Andrews, K., Schweiger, M., Cheng, B., Lindtner, C., et al. (2011). Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab. 13, 183-194. doi: 10.1016/j.cmet.2011.01.008
188. Schmidt, P. T., Naslund, E., Gryback, P., Jacobsson, H., Holst, J. J., Hilsted, L., et al. (2005). A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control. J. Clin. Endocrinol. Metab. 90, 5241-5246. doi: 10.1210/jc.2004-2089
189. Schwartz, M. W., Prigeon, R. L., Kahn, S. E., Nicolson, M., Moore, J., Morawiecki, A., et al. (1997). Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms. Diabetes Care 20, 1476-1481. doi: 10.2337/diacare.20.9.1476
190. Schwartz, T. W. (1983). Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 85, 1411-1425.
191. Scriba, D., Aprath-Husmann, I., Blum, W. F., and Hauner, H. (2000). Catecholamines suppress leptin release from in vitro differentiated subcutaneous human adipocytes in primary culture via beta1-and beta2-adrenergic receptors. Eur. J. Endocrinol. 143, 439-445. doi: 10.1530/eje.0.1430439
192. Seravalle, G., Colombo, M., Perego, P., Giardini, V., Volpe, M., Dell'Oro, R., et al. (2014). Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients. Hypertension 64, 431-437. doi: 10.1161/HYPERTENSIONAHA.113.02988
193. Sheikh, A. (2013). Direct cardiovascular effects of glucagon like peptide-1. Diabetol. Metab. Syndr. 5:47. doi: 10.1186/1758-5996-5-47
194. Sheikh, S. P., Holst, J. J., Orskov, C., Ekman, R., and Schwartz, T. W. (1989). Release of PYY from pig intestinal mucosa; luminal and neural regulation. Regul. Pept. 26, 253-266. doi: 10.1016/0167-0115(89)90193-6
195. Shibao, C., Gamboa, A., Diedrich, A., Ertl, A. C., Chen, K. Y., Byrne, D. W., et al. (2007). Autonomic contribution to blood pressure and metabolism in obesity. Hypertension 49, 27-33. doi: 10.1161/01.HYP.0000251679.87348.05
196. Shikora, S., Toouli, J., Herrera, M. F., Kulseng, B., Zulewski, H., Brancatisano, R., et al. (2013). Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus. J. Obes. 2013:245683. doi: 10.1155/2013/245683
197. Shin, A. C., Zheng, H., and Berthoud, H. R. (2009). An expanded view of energy homeostasis: neural integration of metabolic, cognitive, and emotional drives to eat. Physiol. Behav. 97, 572-580. doi: 10.1016/j.physbeh.2009.02.010
198. Smith, D. K., Sarfeh, J., and Howard, L. (1983). Truncal vagotomy in hypothalamic obesity. Lancet 1, 1330-1331. doi: 10.1016/S0140-6736(83)92437-6
199. Soares, L. P., Fabbro, A. L., Silva, A. S., Sartorelli, D. S., Franco, L. F., Kuhn, P. C., et al. (2015). Prevalence of metabolic syndrome in the Brazilian Xavante indigenous population. Diabetol. Metab. Syndr. 7:105. doi: 10.1186/s13098-015-0100-x
200. Soderlund, V., Larsson, S. A., and Jacobsson, H. (2007). Reduction of FDG uptake in brown adipose tissue in clinical patients by a single dose of propranolol. Eur. J. Nucl. Med. Mol. Imaging 34, 1018-1022. doi: 10.1007/s00259-006-0318-9
201. Somers, V. K., Dyken, M. E., Clary, M. P., and Abboud, F. M. (1995). Sympathetic neural mechanisms in obstructive sleep apnea. J. Clin. Invest. 96, 1897-1904. doi: 10.1172/JCI118235
202. Sondergaard, E., Gormsen, L. C., Christensen, M. H., Pedersen, S. B., Christiansen, P., Nielsen, S., et al. (2015). Chronic adrenergic stimulation induces brown adipose tissue differentiation in visceral adipose tissue. Diabet. Med. 32, e4-e8. doi: 10.1111/dme.12595
203. Straznicky, N. E., Lambert, E. A., Lambert, G. W., Masuo, K., Esler, M. D., and Nestel, P. J. (2005). Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J. Clin. Endocrinol. Metab. 90, 5998-6005. doi: 10.1210/jc.2005-0961
204. Takahashi, A., and Shimazu, T. (1981). Hypothalamic regulation of lipid metabolism in the rat: effect of hypothalamic stimulation on lipolysis. J. Auton. Nerv. Syst. 4, 195-205. doi: 10.1016/0165-1838(81)90044-8
205. Tallam, L. S., Stec, D. E., Willis, M. A., da Silva, A. A., and Hall, J. E. (2005). Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension 46, 326-332. doi: 10.1161/01.HYP.0000175474.99326.bf
206. Tentolouris, N., Tsigos, C., Perea, D., Koukou, E., Kyriaki, D., Kitsou, E., et al. (2003). Differential effects of high-fat and high-carbohydrate isoenergetic meals on cardiac autonomic nervous system activity in lean and obese women. Metab. Clin. Exp. 52, 1426-1432. doi: 10.1016/S0026-0495(03)00322-6
207. Tonhajzerova, I., Javorka, M., Trunkvalterova, Z., Chroma, O., Javorkova, J., Lazarova, Z., et al. (2008). Cardio-respiratory interaction and autonomic dysfunction in obesity. J. Physiol. Pharmacol. 59(Suppl. 6), 709-718.
208. Track, N. S. (1980). The gastrointestinal endocrine system. Can. Med. Assoc. J. 122, 287-292.
209. Travers, J. B., Travers, S. P., and Norgren, R. (1987). Gustatory neural processing in the hindbrain. Annu. Rev. Neurosci. 10, 595-632. doi: 10.1146/annurev.ne.10.030187.003115
210. Trayhurn, P., Duncan, J. S., and Rayner, D. V. (1995). Acute cold-induced suppression of ob (obese) gene expression in white adipose tissue of mice: mediation by the sympathetic system. Biochem. J. 311(Pt 3), 729-733. doi: 10.1042/bj3110729
211. Tschop, M., Wawarta, R., Riepl, R. L., Friedrich, S., Bidlingmaier, M., Landgraf, R., et al. (2001). Post-prandial decrease of circulating human ghrelin levels. J. Endocrinol. Invest. 24(6), Rc19-Rc 21. doi: 10.1007/BF03351037
212. Tupone, D., Madden, C. J., and Morrison, S. F. (2014). Autonomic regulation of brown adipose tissue thermogenesis in health and disease: potential clinical applications for altering BAT thermogenesis. Front. Neurosci. 8:14. doi: 10.3389/fnins.2014.00014
213. Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M., Meeran, K., et al. (1996). A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379, 69-72. doi: 10.1038/379069a0
214. Val-Laillet, D., Biraben, A., Randuineau, G., and Malbert, C. H. (2010). Chronic vagus nerve stimulation decreased weight gain, food consumption and sweet craving in adult obese minipigs. Appetite 55, 245-252. doi: 10.1016/j.appet.2010.06.008
215. Vallbo, A. B., Hagbarth, K. E., and Wallin, B. G. (2004). Microneurography: how the technique developed and its role in the investigation of the sympathetic nervous system. J. Appl. Physiol. (1985) 96, 1262-1269. doi: 10.1152/japplphysiol.00470.2003
216. van Baak, M. A. (2001). The peripheral sympathetic nervous system in human obesity. Obes. Rev. 2, 3-14. doi: 10.1046/j.1467-789x.2001.00010.x
217. van der Lans, A. A., Hoeks, J., Brans, B., Vijgen, G. H., Visser, M. G., Vosselman, M. J., et al. (2013). Cold acclimation recruits human brown fat and increases nonshivering thermogenesis. J. Clin. Invest. 123, 3395-3403. doi: 10.1172/JCI68993
218. van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M., Kemerink, G. J., Bouvy, N. D., et al. (2009). Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 360, 1500-1508. doi: 10.1056/NEJMoa0808718
219. Ventureyra, E. C. (2000). Transcutaneous vagus nerve stimulation for partial onset seizure therapy. A new concept. Childs Nerv. Syst. 16, 101-102. doi: 10.1007/s003810050021
220. Verdich, C., Toubro, S., Buemann, B., Lysgard Madsen, J., Juul Holst, J., and Astrup, A. (2001). The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction. Int. J. Obes. Relat. Metab. Disord. 25, 1206-1214. doi: 10.1038/sj.ijo.0801655
221. Vijgen, G. H., Bouvy, N. D., Leenen, L., Rijkers, K., Cornips, E., Majoie, M., et al. (2013). Vagus nerve stimulation increases energy expenditure: relation to brown adipose tissue activity. PLoS ONE 8:e77221. doi: 10.1371/journal.pone.0077221
222. Virdis, A., Lerman, L. O., Regoli, F., Ghiadoni, L., Lerman, A., and Taddei, S. (2016). Human ghrelin: a gastric hormone with cardiovascular properties. Curr. Pharm. Des. 22, 52-58. doi: 10.2174/1381612822666151119144458
223. Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., et al. (2009). Functional brown adipose tissue in healthy adults. N. Engl. J. Med. 360, 1518-1525. doi: 10.1056/NEJMoa0808949
224. Wang, Z., Yu, L., Wang, S., Huang, B., Liao, K., Saren, G., et al. (2014). Chronic intermittent low-level transcutaneous electrical stimulation of auricular branch of vagus nerve improves left ventricular remodeling in conscious dogs with healed myocardial infarction. Circ. Heart Fail. 7, 1014-1021. doi: 10.1161/CIRCHEARTFAILURE.114.001564
225. Wank, S. A. (1995). Cholecystokinin receptors. Am. J. Physiol. 269(5 Pt 1), G628-646.
226. Welle, S. (1995). Sympathetic nervous system response to intake. Am. J. Clin. Nutr. 62(5 Suppl.), 1118s-1122s.
227. Welle, S., Schwartz, R. G., and Statt, M. (1991). Reduced metabolic rate during beta-adrenergic blockade in humans. Metab. Clin. Exp. 40, 619-622. doi: 10.1016/0026-0495(91)90053-Y
228. Wettergren, A., Maina, P., Boesby, S., and Holst, J. J. (1997). Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man. Scand. J. Gastroenterol. 32, 552-555. doi: 10.3109/00365529709025098
229. Wijers, S. L., Saris, W. H., and van Marken Lichtenbelt, W. D. (2010). Cold-induced adaptive thermogenesis in lean and obese. Obesity 18, 1092-1099. doi: 10.1038/oby.2010.74
230. Williams, D. L., Grill, H. J., Cummings, D. E., and Kaplan, J. M. (2003). Vagotomy dissociates short-and long-term controls of circulating ghrelin. Endocrinology 144, 5184-5187. doi: 10.1210/en.2003-1059
231. Witkowski, A., Prejbisz, A., Florczak, E., Kadziela, J., Sliwinski, P., Bielen, P., et al. (2011). Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 58, 559-565. doi: 10.1161/HYPERTENSIONAHA.111.173799
232. Wofford, M. R., Anderson, D. C. Jr., Brown, C. A., Jones, D. W., Miller, M. E., and Hall, J. E. (2001). Antihypertensive effect of alpha-and beta-adrenergic blockade in obese and lean hypertensive subjects. Am. J. Hypertens 14(7 Pt 1), 694-698. doi: 10.1016/S0895-7061(01)01293-6
233. Woods, A. J., and Stock, M. J. (1996). Leptin activation in hypothalamus. Nature 381:745. doi: 10.1038/381745a0
234. Woods, S. C., Seeley, R. J., Porte, D. Jr., and Schwartz, M. W. (1998). Signals that regulate food intake and energy homeostasis. Science 280, 1378-1383. doi: 10.1126/science.280.5368.1378
235. Xu, X., Chen, D. D., Yin, J., and Chen, J. D. (2014). Altered postprandial responses in gastric myoelectrical activity and cardiac autonomic functions in healthy obese subjects. Obes. Surg. 24, 554-560. doi: 10.1007/s11695-013-1109-6
236. Yang, H. (2002). Central and peripheral regulation of gastric acid secretion by peptide YY. Peptides 23, 349-358. doi: 10.1016/S0196-9781(01)00611-8
237. Yi, C. X., la Fleur, S. E., Fliers, E., and Kalsbeek, A. (2010). The role of the autonomic nervous liver innervation in the control of energy metabolism. Biochim. Biophys. Acta 1802, 416-431. doi: 10.1016/j.bbadis.2010.01.006
238. Yoneshiro, T., Aita, S., Matsushita, M., Kayahara, T., Kameya, T., Kawai, Y., et al. (2013). Recruited brown adipose tissue as an antiobesity agent in humans. J. Clin. Invest. 123, 3404-3408. doi: 10.1172/JCI67803
239. Young, J. B., and Landsberg, L. (1977). Stimulation of the sympathetic nervous system during sucrose feeding. Nature 269, 615-617. doi: 10.1038/269615a0
240. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432. doi: 10.1038/372425a0